Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate for oligozoospermia in men attending an infertility clinic
PACTR202512521032169Phase 2Not yet recruiting
- Sponsor
- Festus Udobor
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clomiphene in male infertility and oligospermia, sponsored by Festus Udobor. Primary endpoints: Mean change in total sperm count and Mean change in sperm concentration. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
clomiphene
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on PACTR202512521032169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512521032169.